Publications by authors named "G Jimenez Riera"

Orchard and tree-child networks share an important property with phylogenetic trees: they can be completely reduced to a single node by iteratively deleting cherries and reticulated cherries. As it is the case with phylogenetic trees, the number of ways in which this can be done gives information about the topology of the network. Here, we show that the problem of computing this number in tree-child networks is akin to that of finding the number of linear extensions of the poset induced by each network, and give an algorithm based on this reduction whose complexity is bounded in terms of the level of the network.

View Article and Find Full Text PDF
Article Synopsis
  • Faith's Phylogenetic Diversity (PD) showcases a strong exchange property that facilitates moving leaves between sets without decreasing diversity, leading to an efficient greedy solution for optimizing PD on rooted trees.
  • The study introduces an exchange property specifically for rooted Phylogenetic Subnet Diversity (rPSD) on phylogenetic networks, which requires a more intricate approach to exchanging leaves.
  • Utilizing this new exchange property, the researchers develop a polynomial-time greedy solution for optimizing rPSD in rooted semibinary level-2 phylogenetic networks.
View Article and Find Full Text PDF

Background: About 70% of neurologists report that PD patients do not get their medication properly when hospitalized, and 33% are prescribed contraindicated drugs.

Objectives: To execute medication reconciliation (MedRec) focused on antiparkinsonian drugs to identify, characterize and, eventually, prevent medication errors, thus promoting therapeutic quality and safety in daily practice.

Methods: An interventional, single-center, 1 year, prospective study.

View Article and Find Full Text PDF

Introduction: The objective of this report is to describe the clinical pathway for early treatment of patients with acute SARS-CoV-2 infection and to evaluate the first results of its implementation.

Methods: This is a descriptive and retrospective study of the implementation of a clinical pathway of treatment in outpatients (January 1 to June 30 2022). Clinical pathway: detection and referral systems from Primary Care, Emergency services, hospital specialities and an automated detection system; clinical evaluation and treatment administration in the COVID-19 day-hospital and subsequent clinical follow-up.

View Article and Find Full Text PDF
Article Synopsis
  • The report outlines a clinical pathway for early treatment of acute SARS-CoV-2 infection in outpatients and assesses its initial effectiveness.
  • The study reviewed the treatment process for 262 patients from January to June 2022, focusing on demographics, comorbidities, and treatment outcomes, with a majority receiving remdesivir or nirmatrelvir/ritonavir.
  • Results showed low hospitalization rates (6.1%) and no deaths, but some patients experienced significant treatment-related side effects, indicating that the pathway improves access to treatment while monitoring for toxicity.
View Article and Find Full Text PDF